Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-Bound Paclitaxel and Gemcitabine in Squamous Cell Lung Cancer
NCT02525653Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2015
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in squamous cell carcinoma of the lung (LSCC), sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2015; status: completed.
02
Drugs
paclitaxel
03
Conditions
squamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT02525653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02525653.